Medtronic (MDT) Granted FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

February 19, 2019 6:58 AM EST Send to a Friend
Medtronic plc (NYSE: MDT) today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login